PMID: 16514772 11
The following drugs are SGLTi, brand name and generic name in brackets: Invokana (Canagliflozin) Forxiga (Dapagliflozin) Jardiance (Empagliflozin) Steglatro (Ertugliflozin) All are in tablet form and are taken in the morning, usually at breakfast time
By February 2026, eight GLP-1 RAs have received FDA approval, primarily for glycemic control in T2D and chronic weight management in obesity, with expanding cardiovascular (CV) benefits demonstrated in large-scale trials
These changes are associated with faster development of cataracts in knockout mice compared to wild-type mice
This provides dietary fiber with beneficial nutrients that supplements don't contain
[5] [6] Exenatide is administered via subcutaneous injection and works by enhancing glucose-dependent insulin secretion, suppressing inappropriate glucagon release, slowing gastric emptying, and promoting satiety